attenuates respiratory complications associated with the obese phenotype. J. Appl. Physiol. 85(6): 2261-2269, 1998.-A profile of respiratory complications has been associated with the onset and development of obesity in humans. Similar phenotypes have been routinely demonstrated in genetic animal models of obesity such as the ob mouse (C57BL/6J-Lep ob ). The objective of the present study was to test the hypothesis that a constellation of respiratory complications are attenuated with leptin (i.e., protein product of the ob gene) replacement. Daily leptin administration during a 6-wk period was conducted to control body weight of mutant ob mice similar to genotypic control groups. During the treatment period, repeated baseline ventilatory measurements were assessed by using whole body plethysmography while quasistatic pressure-volume curves were performed to further explore the role of leptin in improving lung mechanics. Diaphragmatic myosin heavy chain (MHC) isoform phenotype was examined to determine proportional changes in MHC composition. In room air, breathing frequency and minute ventilation were significantly (P Ͻ 0.01) different among ob treatment groups, suggesting that leptin opposed the development of a rapid breathing pattern observed in vehicle-treated ob mice. Quasistatic deflation curves indicated that the lung volume of leptin-treated ob mice was significantly (P Ͻ 0.05) greater relative to vehicle-treated ob mice at airway pressures between 0 and 30 cmH 2 O. Diaphragm MHC composition of leptin-treated ob mice was restored significantly (P Ͻ 0.05) to resemble the control phenotype. In this genetic mouse model of obesity, the results suggested that respiratory complications associated with the obese phenotype, including rapid breathing pattern at baseline, diminished lung compliance, and abnormal respiratory muscle adaptations, are attenuated with prolonged leptin treatment.
animal models of obesity (e.g., Refs. 31 and 34) have suggested that during both sleep and wakefulness genetic determinants confer anomalies in respiratory control mechanisms free of weight-dependent effects. When examining awake rats of four inbred strains, including two strains susceptible to obesity, Strohl et al. (31) highlighted important genetic factors to explain strain differences in breathing patterns at baseline that were independent of covarying body weight effects. In contrast, baseline ventilatory changes in obese humans have been thought to be mainly due to an increased pulmonary elastance and reductions in lung volume (e.g., Ref. 22) . The weight-dependent mechanical changes imposed on the chest wall are generally accompanied by a cephalad displacement of the diaphragm and increased intra-abdominal pressure. To understand the impact of obesity on lung structure and function, one must distinguish between respiratory complications associated with increased adiposity and other intrinsic features, including genetic determinants. The present study was designed to control the development of obesity, so as to explore the residual susceptiblity to potential respiratory complications.
In the ob murine model, ventilatory anomalies included a rapid breathing pattern at baseline, which develops predominantly between 30 and 80 days of age (a time interval in which a precipitous increase in body weight occurred) (34) . Localized to mouse chromosome 6 (9, 38) , the ob gene mutation routinely confers an obese phenotype in C57BL/6J inbred mice with the homozygous genotype (ob/ob). Leptin, a 16.5-kb endocrine product of the ob gene, has been shown to be a powerful satiety factor that is synthesized and secreted by adipocytes (3, 11, 21) . There are functionally similar effects of leptin in mice and humans (e.g., Refs. 5 and 30); these effects include a depression in food consumption, an increase in caloric expenditure, and an elevation in deep-body temperature (T db ). In addition, leptin has been shown to play a pivotal role in the prepubertal development of reproductive functions (2, 4) . We postulate that the coincident time course between the development of rapid breathing and the onset of obesity suggests a role for leptin in age-dependent changes in lung structure and function. Therefore, one aim of the present study is to focus on changes in ventilatory control at baseline in a series of ob mice in the presence or absence of leptin replacement.
These studies extend our previous findings that describe obesity-hypoventilatory traits in the ob mouse model (36) by describing the influence of leptin on the The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
baseline breathing pattern, quasistatic pressure-volume (P-V) relationships, and diaphragmatic muscle fiber typing. The results indicate that leptin modulates the development of baseline respiratory complications associated with obesity. These data also support the hypothesis that leptin acts primarily to prevent an obesity-induced rapid breathing pattern at baseline by attenuating mechanical changes that foster reductions in lung volume. Therefore, leptin may potentially play an important role in normal lung growth and development.
METHODS
Animals. Male and female C57BL /6J-Lep ob homozygotes (ob) are infertile in the absence of leptin. The ob gene mutation is routinely propagated by breeding heterozygotes (ob/ϩ) within the C57BL/6J (B6) inbred strain. That is, the offspring of ob/ϩ progenitors consist of homozygotes and congenic littermates (?/ϩ) in a 25:75 ratio. In the present study, all animals, including wild-type (ϩ/ϩ) mice, were weaned at 21-28 days of age and were genotypically identified by Jackson Laboratory (Bar Harbor, ME) before their procurement. The animals were housed in a facility at The Johns Hopkins University; the temperature was maintained at ϳ21.5°C, and the light-dark cycle was 12:12 h, beginning at 0700. Ventilatory data were randomly sampled between 0900 and 1800 at chamber temperatures between 26 and 28°C. Water and mouse chow (Agway Pro-Lab RMH 1000) were provided ad libitum throughout the studies described below.
Leptin administration. When mutant and control mice were received at 28-32 days of age, the average body weight of the ob/ob mice was determined to be ϳ15% greater (P Ͻ 0.05) relative to age-matched control groups. On a daily basis, each animal was weighed, and an adjusted dose of recombinant murine leptin (r-metmuleptin; Amgen) was intraperitoneally administered intended to manage body weight of a subgroup of ob mice (n ϭ 12) to resemble lean control groups. Vehicle-treated ob mice (n ϭ 4) were administered physiologically based saline at an average volume equivalent to that for leptin-treated animals. In most cases, the time of day at which leptin administration occurred was within several hours (i.e., 1200-1600) of the natural peak in serum leptin levels (1, 30) . As shown in Fig. 1 , daily leptin was administered at a dose of 5 mg/kg of body weight immediately after studies to assess pretreatment ventilatory characteristics. Increases in the average daily dose of leptin occurred within weeks 1 and 2, followed by a period during which the dose required to manage body weight remained relatively constant (weeks 3 and 4). During weeks 5 and 6 of leptin treatment, the daily dose was gradually reduced.
In addition to assessment of body weight on a daily basis, body temperature was measured each week to further assess leptin treatment efficacy. Colonic temperature was measured by using a Type-T thermocouple encased in polyethylene tubing (PE-10) as an indicator of T db . Animal handling procedures were standardized, and time of day was maintained between 1200 and 1400. Because acute measurements of colonic temperature can result in stress-induced increases in T db that may differ between lean and obese animals (29), we measured T db by using radiotelemetry (Data Sciences). In exploratory studies, we were unable to detect differences between wild-type and mutant animals in the diurnal regulation of T db . Furthermore, leptin-treated ob/ob mice demonstrated an elevated T db only during the light phase of the 12:12-h light-dark cycle, when T db was predictably at a nadir.
Whole body plethysmography. The methods used to assess ventilatory characteristics have been described in detail elsewhere (6, 34, 35) . Briefly, whole body plethysmography was used in combination with a standard hypercapnic-and hypoxic-challenge protocol to assess ventilatory responses in unanesthetized, unrestrained mice. Baseline ventilatory function was assessed by computing the average of five intermittent room air measurements. Each animal was permitted to acclimate within the chamber for at least 30 min before the beginning of the protocol. Chamber temperature was maintained within the thermoneutral zone for mice (i.e., 26-28°C) and was recorded with each ventilatory measurement by using a Type-T thermocouple. Compressed air was humidified (90% relative humidity) and directed through the chamber at a flow rate of ϳ300 ml/min. After the animal became quiescent, breathing frequency (f), tidal volume (VT), and inspiratory time (TI) were recorded on a strip-chart recorder (Grass Polygraph, model 7D). At a constant chamber volume, changes in pressure due to inspiratory and expiratory temperature fluctuations were measured by using a differential pressure transducer (model 8510B-2, Endevco). As shown in Fig. 1 , ventilatory data were repeatedly measured in leptinand vehicle-treated animals after 3, 13, 20, 28, 35, and 42 days of treatment.
Quasistatic P-V curves. After repeated ventilatory measurements, leptin-and vehicle-treated ob mice at 75-85 days of age, as well as control animals, were prepared for quasistatic P-V curves. Animals were anesthetized with intraperitoneal injections of pentobarbital sodium at a dose of ϳ70-80 mg/kg body weight. After the trachea was cannulated and while the animal was in a supine position, each animal was ventilated with 100% oxygen for 10 min before the cannula was sealed with a stopcock to degas the lung (8) . Quasistatic P-V curves were immediately performed in situ, at least two times each, with the respiratory system intact and with the thorax widely opened. The rate of inflation and deflation was standardized by a dual infusion-withdraw pump (model 900-610, Harvard Apparatus, Dover, MA), and the airway pressure was measured by using a differential pressure transducer (model 8510B-2, Endevco). The initial inflation rate was controlled at ϳ0.5 ml/min to ensure that all lung regions opened before being switched to a rate of 2.1 ml/min for the remaining inflation-deflation manuevers. The limits of the inflation and deflation airway pressures were 30 and Ϫ5 cmH 2 O, respectively.
Residual volume (RV -5 ) and total lung capacity (TLC 30 ) were determined as the volume on deflation at Ϫ5 and 30 cmH 2 O, respectively, with the respiratory system intact (13) . FRC was also determined on deflation at 0 cmH 2 O. Compliance of both the respiratory system intact (Crs) and lung only was computed as the slope of the P-V relationship between 0 and 10 cmH 2 O on deflation. The shape of the P-V relationship was further examined by normalizing intermediate volumes for differences in TLC 30 .
Diaphragm myosin heavy chain (MHC) composition. Diaphragm muscle was excised from young and older groups of animals to establish age and genotypic effects. Diaphragm tissue was obtained from 7-wk-old animals which were subsequently used in other studies. In additon, diaphragm tissue was obtained from older animals at 350 days of age for the ob mice and at 480 days in the remaining genotypic classes. Ventilatory data from these groups of animals were previously reported elsewhere (34) . In animals used to assess the effects of leptin, diaphragm tissue was obtained after the quasistatic P-V manuever. Each animal was anesthetized with pentobarbitol sodium (80 mg/kg) before tissue was excised, and samples were immediately frozen and stored at -70°C for subsequent classification of MHC composition.
Myosin extractions and MHC electrophoresis were performed as previously described (37) . Briefly, myosin for electrophoresis was prepared by scissor-mincing the muscle tissue in a high-salt solution, pH 6.5, at 4°C for 40 min. Extracts were centrifuged, and supernatants were recovered and treated as follows. Electrophoresis of MHC isoforms was performed by using the method of Talmadge and Roy (33) . Then 10 µl of supernatant were diluted (1:10) in a low-salt buffer consisting of 1 mM EDTA and 0.1% 2-mercaptoethanol and were stored overnight at 4°C to allow precipitation of myosin filaments. The filament solution was subsequently centrifuged to form a pellet, which was then dissolved in myosin sample buffer (0.5 M NaCl, 10 mM NaH 2 PO 4 , pH 7.0) followed by dilution of 1:100 in SDS sample buffer [62.5 mM Tris · HCl, 2% (wt/vol) SDS, 30% glycerol, 5% (vol/vol) 2-mercaptoethanol, and 0.001% (wt/vol) bromophenol blue at pH 6.8]. The samples were boiled for 2 min and stored at Ϫ80°C.
Gels were prepared from a stock solution of 30% acrylamide that contained 29.4% (wt/vol) acrylamide and 0.6% N,NЈmethylene-bis-acrylamide (Bis). Electrophoresis was performed on slabs (18 ϫ 16 ϫ 0.75 mm thick) consisting of an 11.5-cm separating gel and a 4.5-cm stacking gel. Separating gels of total concentration of monomer (acrylamide ϩ Bis) (T) ϭ 8%, and stacking gels of T ϭ 4% at percentage of total monomer due to Bis (C) ϭ 2% were used. Volumes of myosin extract (1-3 µl) containing 500-1,000 ng of protein per well were loaded on the gels. Electrophoresis (275 V for 3.5 h and then 178 V for 17.5 h) was performed by using a vertical-slab gel unit (SE600, Hoefer Scientific Instruments) with a Trisglycine-SDS running buffer in a cold room maintained at 4°C (33) . Separating gels were silver stained.
MHC gels were analyzed by using a scanning densitometer (GS 300, Hoefer Scientific) and densitometry software (GS 365, Hoefer Scientific) to quantify the area under individual isoform peaks.
Data analysis. In computing VT, the amplitude of the inspiratory and expiratory limbs of each tidal breath were averaged over ϳ15 consecutive breaths, and body temperature of each animal was assumed to be constant at 37°C. Although the resting T db was shown to differ among treatment groups, the magnitude was within ϳ1-2°C (see Fig.  2B ), accounting for Ͻ5-10% error in computing baseline VT. Minute ventilation (V E) was calculated as the product of f and VT. TE was determined from total respiratory time (T tot ) minus TI, mean inspiratory flow was calculated as the ratio of VT to TI, and the respiratory duty cycle was computed as the ratio of TI to T tot .
Data were summarized in the figures and tables as means Ϯ SE. Ventilatory responses during room air exposure represented the average of five intermittent measurements and were analyzed by two-way ANOVA corrected for repeated measures to test for effects of time and leptin administration. Two-way ANOVAs were also performed to detect significant differences due to genotypic and leptin effects in the quasistatic deflation curves and in the proportional diaphragmatic MHC isoform composition. Time-dependent significant mean comparisons between treatment and genotypic groups were detected by using a Duncan's multiple-range test. For each statistical test, the confidence level was maintained at 95%.
RESULTS
Body weight and temperature. As shown in Fig. 2A , the average (mean Ϯ SE) body weight of the leptintreated ob mice during the 6-wk treatment was maintained within a range between 27.1 Ϯ 0.6 and 30.4 Ϯ 0.7 g. The average body weight of the control groups T db is shown in Fig. 2B for the leptin-and vehicletreated ob mutants relative to the ?/ϩ control mice. Vehicle-treated ob mice demonstrated a significantly (P Ͻ 0.05) lower T db compared with both the leptintreated and control mice within the first week of leptin administration.
Room air ventilation. The magnitude and pattern of breathing at baseline are illustrated in Fig. 3 . The baseline V E response in vehicle-treated ob mice was significantly (P Ͻ 0.05) elevated during the 6-wk treatment compared with the leptin-treated ob and control mice (Fig. 3A) . There were no significant differences in VT, but f was significantly (P Ͻ 0.05) elevated above the pretreatment response by 45 days of age in vehicletreated ob mice (Fig. 3, B and C, respectively) . The increases in baseline f and V E were not observed in leptin-treated ob mice. Therefore, leptin treatment appeared to significantly (P Ͻ 0.01) inhibit the development of a rapid breathing pattern at baseline and the rise in V E that normally occurred in ob mutants. Figure 4 demonstrates the time-dependent changes in TI and TE. The development of rapid breathing in vehicle-treated ob mice was accompanied by significant (P Ͻ 0.01) differences in both TI and TE relative to leptin-treated ob mice. Initially, the leptin-treated ob mice demonstrated a significant (P Ͻ 0.05) decline in TI within the first 3 days of treatment and then returned toward the average TI response of the ob/ϩ control. The modest decline in TE which developed in vehicletreated ob mice differed from the significant (P Ͻ 0.05) increase in TE observed in leptin-treated ob and control ob/ϩ mice.
As shown in Fig. 5 , the mean inspiratory flow (VT/TI) increased steadily (P Ͻ 0.05) in vehicle-treated ob mice. In contrast, the mean inspiratory flow of the leptin- http://jap.physiology.org/ treated ob and control mice remained unchanged with time, leading to a significant (P Ͻ 0.01) difference between vehicle-and leptin-treated ob mice beyond 45 days of age. There were no consistent differences in the respiratory duty cycle (TI/T tot ) among vehicle-and leptin-treated and control mice (data not shown).
Quasistatic P-V relationships. Figure 6 depicts lung deflation curves with and without the chest wall intact for vehicle-and leptin-treated ob mice and for each genotypic control group. The lung volume of vehicletreated ob mice was significantly (P Ͻ 0.01) attenuated at airway pressures between 0 and 30 cmH 2 O compared with each of the genotypic control groups (i.e., ϩ/ϩ, ?/ϩ, and ob/ϩ). In a similar range of airway pressures, leptin-treated ob mice demonstrated significantly (P Ͻ 0.05) greater lung volumes relative to the vehicle-treated ob mice, but these volumes were still significantly (P Ͻ 0.05) less than those of the controls. There were no significant (P Ͼ 0.05) differences between groups in the percent deflation volume when volumes were normalized by TLC (data not shown).
This similarity among groups indicated that the differences in absolute P-V relationships were primarily a volume-dependent effect.
Compliance and lung volumes are summarized in Table 1 . Relative to the genotypic control groups, the vehicle-treated ob mice demonstrated significantly (P Ͻ 0.01) lower lung volumes (i.e., RV -5 , FRC, and TLC 30 ) and lung compliance. The FRC and TLC 30 parameters of leptin-treated ob mice were significantly (P Ͻ 0.05) greater compared with vehicle-treated counterparts. There were significant (P Ͻ 0.05) differences also detected between leptin-and vehicle-treated ob mice relative to Crs and lung compliance.
Diaphragm MHC phenotype. Table 2 shows the proportional diaphragmatic MHC composition for young and older groups of mutant and genotypic control mice. In each of the genotypic classes, an age-dependent change in the diaphragm MHC isoform composition was observed favoring a significant (P Ͻ 0.05) reduction in the percentage of MHC type IIx isoform. In addition, older ob mice demonstrated a significant (P Ͻ 0.01) increase in MHC type I composition relative to genotypic controls. This was accompanied by a significantly (P Ͻ 0.01) greater proportion of MHC type IIa and reduced proportion of MHC type IIx. The most apparent change in older ob mice was the significantly (P Ͻ 0.01) diminished percentage of MHC type IIb, to the extent that this MHC isoform was undetectable in a majority of individual samples. Because this phenotypic transition was observed in younger ob mice at ϳ7 wk of age, a time-dependent association corresponded to the significant change in the rapid breathing pattern at baseline (Fig. 3A) .
The effects of leptin treatment are also reported in Table 2 . At ϳ12 wk of age, leptin significantly opposed the phenotypic transition in diaphragmatic MHC composition that occurred in vehicle-treated ob mice. Specifically, leptin-treated ob mice showed a significantly (P Ͻ 0.05) lower percentage of MHC type I and MHC type IIa isoforms accompanied by a significantly (P Ͻ 0.01) larger proportion of MHC type IIx compared with vehicle-treated ob mice. The profile of diaphragmatic MHC composition in leptin-treated ob mice was remarkably similar to that in the genotypic control groups; that is, there were no detectable differences between leptin-treated ob mice and the other genotype classes.
DISCUSSION
Leptin replacement in ob mice attenuates a variety of respiratory alterations, including volume-dependent lung mechanical properties and respiratory muscle adaptations coincident with a significant reduction in the development of rapid breathing at baseline. It is difficult to determine from the results whether the changes in structure and function were caused by factors associated with weight control or by a more direct effect of leptin on lung growth. The evidence suggests that there may be an interaction between both mechanisms. These results extend the obese phenotype to involve additional characteristics of respiratory alterations, such as a reduced lung compliance and an altered diaphragmatic MHC composition which favors fatigue resistance. A similar phenotypic profile, relating lung function and structure, has been characterized in morbidly obese humans (17, 20, 28, 32) , although the ob mutation is rarely found in obese human populations (18) .
The major effects of leptin are involved in satiety and metabolism (3, 11, 21) . Leptin acts as a satiety factor and thus reduces food intake. Leptin also acts as a metabolic factor to stimulate oxygen consumption and elevate body temperature. In addition, the results of the present study suggest leptin's effects influence the control of ventilation at baseline. In vehicle-treated ob mice, the baseline V E progressively increases during the period of 30-80 days of age, primarily due to the onset of a rapid breathing pattern (Fig. 3C) . In leptintreated ob mice, the magnitude and pattern of baseline breathing are not altered from pretreatment responses and resemble those in control ob/ϩ mice. Concurrently, body weight gain is curtailed in leptin-treated ob mice within a 3-g range and resembles control groups by the end of the 6-wk treatment period ( Fig. 2A) . Consistent with previous studies (11) , body temperature in the present study is significantly lower in the vehicletreated ob mice compared with leptin-treated and control groups (Fig. 2B) . The time course of these results suggests that the changes in ventilatory control at baseline are coupled with the leptin-induced maintenance of body weight and temperature regulation.
Because the predominant regulatory mechanism for leptin is mediated via leptin receptors in the hypothalamus (7, 10, 29) , an influence on the central integration of breathing may involve a similar mechanism. The hypothesis that leptin involves a neural component is further supported by the influential effect of leptin in stabilizing mean inspiratory flow at baseline (Fig. 5) . Compared with leptin-treated and control mice, vehicle- treated ob mice demonstrate a progressive and significant increase in mean inspiratory flow that implies a difference in the neural ''drive'' to breathe (19) . However, with leptin deficiency, the 50-60% increase in ventilation (Fig. 3) occurs in the face of mechanisms that presumably lead to hypometabolism and hypothermia characteristic of ob mice. Therefore, the effect of leptin on baseline ventilation is not likely coupled with a restoration of metabolism or temperature regulation.
It is also possible that the imposition of abdominal adiposity (22) and the displacement of the diaphragm require a greater neural input per tidal breath (26) . With this mechanism, the development of a phenotype with rapid breathing at baseline would accompany a diaphragmatic muscle adaptation. This implies that leptin's action in stabilizing the magnitude and pattern of baseline ventilation may involve a secondary effect mediated by leptin-induced weight control. The most dramatic change in baseline ventilation occurs between 35 and 45 days of age in vehicle-treated ob mice. During this time interval, a coincident 23% increase in body weight (i.e., from 35.4 Ϯ 0.6 to 43.4 Ϯ 0.7 g) develops in the leptin-deficient mice, while the rapid breathing pattern is influenced by 12 and 21% reductions in TI and TE, respectively. Therefore, the development of rapid breathing in vehicle-treated ob mice is likely due, in part, to the accelerated weight gain and the imposition of fatness on the mechanical properties of the lung and chest wall. This hypothesis is explored by performing quasistatic P-V curves in treated and control mice. Because of the decline in TE observed in vehicle-treated ob mice, we emphasize the deflation curve to illustrate group differences in compliant properties of the lung.
Effect of leptin on the lung compliance and chest wall compliance. As shown in Fig. 6 , the lung volume is significantly lower at every airway pressure in vehicletreated ob mice compared with leptin-treated and control mice. Although there are no detectable differences among the control groups, leptin-treated ob mice demonstrate significantly lower lung volumes for a given airway pressure compared with each control group. Furthermore, there are no detectable differences in lung volume between the results obtained with the respiratory system intact in comparison with the lung only. These results are consistent with previously described P-V relationships in mice; this suggests that the compliance of the relaxed chest wall of the mouse is much greater than that of the lung (15, 36) . Thus the influence of exaggerated intrathoracic adiposity is mediated through an effect on the lung only. The mechanism by which the excess adipose tissue within the thorax and lung leads to decreased lung volume and compliance is not yet understood. An alternative explanation involves the imposition of abdominal fatness, thus forcing the cephalad-displaced diaphragm to restrict lung inflation and to promote lung recoil on deflation. Exploratory studies in isolated lung preparations suggest that this is not a likely explanation, because little difference is observed in the lung deflation curves between in situ and isolated lung conditions. In human obesity, the restriction imposed on the lung by adipose tissue has been suggested to develop via a similar mechanical process. An increased elastance of the respiratory system in conscious obese individuals has been shown to involve reductions in lung volume and compliance. Respiratory system stiffening has been observed in the presence or absence of changes in chest wall compliance (20, 22, 32) . This is also observed in the present results, in which the same lung volume reductions in the obese model are found with or without the intact chest wall. Furthermore, the effects of leptin appear to facilitate lung growth and development in ob mutant mice by increasing lung compliance via volumedependent mechanisms. Although leptin restores and stabilizes the baseline ventilatory function in mutant ob mice, the 6-wk treatment protocol incompletely rejuvenates lung mechanical behavior. Future studies are required to assess whether leptin acts directly on lung growth or whether its action is permissive and limited to a weight-management factor. The possibility that leptin is involved in lung growth and development is further supported by recent evidence related to the prepubertal role of leptin in reproductive development (2, 4, 12) .
The rapid breathing pattern shown in morbidly obese humans is believed to be a load compensatory mechanism in response to attenuated respiratory system compliant changes. Sampson and Grassino (28) demonstrated a rapid breathing pattern accompanying an increase in inspiratory neuromuscular drive, as measured by airway occlusion pressure in 0.1 s (significant differences in VT/TI were not evident). These authors suggested that an increase in the neural ''drive'' was indicative of a recruitment of ancillary inspiratory muscles and departure from a predominantly diaphragmatic contribution to tidal breathing. Rochester (26) suggested that a rapid breathing pattern of obese humans was consistently associated with increased work and ventilatory drive to breathe. In the present study, we observed a similar increase in baseline inspiratory ''drive'' in the obese phenotype. Although the alterations in the diaphragm muscle composition of vehicle-treated ob mice suggest an adaptation to improved efficiency in terms of fatigue resistance, additional functional studies are required.
Effect of leptin on the diaphragm MHC composition. The differences in diaphramatic muscle MHC composition indicate that an adaptation occurs in vehicletreated and older untreated ob mutants. There is a significantly greater proportion of MHC type I to the total MHC phenotype, which is accompanied by a significant decrease in MHC type IIb in young and older ob mutants relative to the other genotypic classes. This shift in MHC isoform composition in ob mice would favor enhanced fatigue resistance. Powers et al. (24) showed similar age-dependent shifts in diaphragm muscle structure and function in obese Zucker rats. These investigators further suggested that the shift in MHC isoforms increased the efficiency of energy utilization and delayed fatigue. In the present study, vehicletreated ob mutants demonstrate an increased f (i.e., an http://jap.physiology.org/ important aspect in provoking fatigue resistance) at ϳ7 wk, which is coincident with the adaptive shift in diaphragmatic muscle composition. In leptin-treated ob mice, the increase in f does not occur, and the changes in diaphragmatic muscle composition are not apparent. Therefore, leptin treatment appears to oppose the remodeling of the respiratory muscle by preventing the obesity-induced rapid breathing pattern.
Evidence from the present study suggests that leptin significantly improves the rapid breathing pattern at baseline that develops in vehicle-treated ob mice. One prominent mechanism might involve the leptin-dependent improvement in reducing the abnormal mechanical load on the lung. The imposition of adipose tissue may significantly reduce lung volume and compliant properties that appear to be partially reversible with leptin treatment in ob mice. The diaphragmatic MHC composition appears to be adaptable and influenced by leptin treatment. That is, a fatigue-resistant MHC phenotype develops within 7 wk of age in vehicletreated ob mice concurrent with the onset of rapid breathing at baseline. Leptin treatment appears to suppress the diaphragm muscle adaptation that is associated with obesity and facilitates a MHC phenotype consisting of a greater proportion of a MHC type IIx and lower proportion of the MHC type I isoform.
One hypothesis considers the role leptin plays in lung growth and development. Recent evidence (12) suggests that the placenta is a significant source of leptin, which also plays a role in intrauterine and neonatal development. Because ob mice are propagated in ϩ/ϩ or ob/ϩ dams (i.e., leptin-sufficient mice), ob/ob offspring are presumably exposed to leptin in utero. However, the absence of leptin during periods of postnatal development may irreversibly influence lung growth and development to provoke reduced lung volume and compliance. This factor (i.e., neonatal leptin deprivation) could account for the attenuated P-V relationship in leptin-treated mutants compared with the untreated control groups (Fig. 6) . As indicated by differences in lung volume between leptin-and vehicle-treated ob/ob mice, leptin administration initiated at 28 days may be significant to the remaining lung growth that occurs during intermediate development. In conclusion, the volume-dependent decrease in lung compliance observed in vehicle-treated ob mice is the prominent factor causing an onset of a rapid breathing pattern at baseline. When lung volume of ob mice is restored with leptin treatment, the phenotype with rapid breathing at baseline and with the remodeling of the diaphragm does not develop.
